Literature DB >> 21933859

MLL-ENL leukemia burden initiated in femoral diaphysis and preceded by mature B-cell depletion.

Agnieszka Jaracz-Ros1, Daniel Lewandowski, Vilma Barroca, Catherine Lavau, Paul-Henri Roméo.   

Abstract

BACKGROUND: Molecular and cellular events that resulted in leukemia development are well characterized but initial engraftment and proliferation of leukemic cells in bone marrow and early modifications of the bone marrow microenvironment induced by engrafted leukemic cells remain to be clarified. DESIGN AND METHODS: After retro-orbital injection of 1,000 leukemic cells expressing Mixed Lineage Leukemia-Eleven Nineteen Leukemia fusion protein in non-conditioned syngenic mice, kinetics of leukemic burden and alterations of femoral hematopoietic populations were followed using an in vivo confocal imaging system and flow cytometry.
RESULTS: Three days after injection, 5% of leukemic cells were found in femurs. Little proliferation of engrafted leukemic cells could then be detected for more than two weeks while the number of femoral leukemic cells remained stable. Twenty days after injection, leukemic cells preferentially proliferated in femoral diaphysis where they formed clusters on the surface of blood vessels and bone. B220(+) lymphoid cells were found near these leukemic cell clusters and this association is correlated with a decreased number of femoral B220(+)IgM(+) cells. Increasing the number of injected leukemic cells or conditioning recipient mice with γ-irradiation resulted in leukemic cell development in diaphysis and knee. Competition experiments indicate that proliferation but not engraftment is a rate-limiting factor of leukemic cells spreading in diaphysis. Finally, 30 days after injection leukemia developed.
CONCLUSIONS: After retro-orbital injection of 1,000 leukemic cells expressing Mixed Lineage Leukemia-Eleven Nineteen Leukemia into syngenic mice, leukemic cell burden preferentially initiates in femoral diaphysis and is preceded by changes of femoral B-lymphoid populations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21933859      PMCID: PMC3232258          DOI: 10.3324/haematol.2011.045153

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  Optical imaging of PKH-labeled hematopoietic cells in recipient bone marrow in vivo.

Authors:  Nadir Askenasy; Daniel L Farkas
Journal:  Stem Cells       Date:  2002       Impact factor: 6.277

2.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.

Authors:  C Lavau; S J Szilvassy; R Slany; M L Cleary
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

Review 3.  Microenvironmental niches in the bone marrow required for B-cell development.

Authors:  Takashi Nagasawa
Journal:  Nat Rev Immunol       Date:  2006-02       Impact factor: 53.106

4.  Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia.

Authors:  Tim C P Somervaille; Michael L Cleary
Journal:  Cancer Cell       Date:  2006-10       Impact factor: 31.743

5.  MLL-GAS7 transforms multipotent hematopoietic progenitors and induces mixed lineage leukemias in mice.

Authors:  Chi Wai So; Holger Karsunky; Emmanuelle Passegué; Antonio Cozzio; Irving L Weissman; Michael L Cleary
Journal:  Cancer Cell       Date:  2003-02       Impact factor: 31.743

6.  In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment.

Authors:  Dorothy A Sipkins; Xunbin Wei; Juwell W Wu; Judith M Runnels; Daniel Côté; Terry K Means; Andrew D Luster; David T Scadden; Charles P Lin
Journal:  Nature       Date:  2005-06-16       Impact factor: 49.962

7.  Growth characteristics of acute myelogenous leukemia progenitors that initiate malignant hematopoiesis in nonobese diabetic/severe combined immunodeficient mice.

Authors:  L E Ailles; B Gerhard; H Kawagoe; D E Hogge
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

8.  Low SCL/TAL1 expression reveals its major role in adult hematopoietic myeloid progenitors and stem cells.

Authors:  Philippe Brunet de la Grange; Florence Armstrong; Veronique Duval; Marie-Christine Rouyez; Nicolas Goardon; Paul-Henri Romeo; Françoise Pflumio
Journal:  Blood       Date:  2006-07-18       Impact factor: 22.113

Review 9.  Biology of normal and acute myeloid leukemia stem cells.

Authors:  John E Dick; Tsvee Lapidot
Journal:  Int J Hematol       Date:  2005-12       Impact factor: 2.490

10.  Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow.

Authors:  Yoshihiro Ueda; Motonari Kondo; Garnett Kelsoe
Journal:  J Exp Med       Date:  2005-06-06       Impact factor: 14.307

View more
  3 in total

Review 1.  ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.

Authors:  Jianbiao Zhou; Yvonne Ng; Wee-Joo Chng
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

2.  Hypoxia favors chemoresistance in T-ALL through an HIF1α-mediated mTORC1 inhibition loop.

Authors:  Lucine Fahy; Julien Calvo; Sara Chabi; Laurent Renou; Charly Le Maout; Sandrine Poglio; Thierry Leblanc; Arnaud Petit; André Baruchel; Paola Ballerini; Irina Naguibneva; Rima Haddad; Marie-Laure Arcangeli; Frederic Mazurier; Francoise Pflumio; Benjamin Uzan
Journal:  Blood Adv       Date:  2021-01-26

3.  Speed of leukemia development and genetic diversity in xenograft models of T cell acute lymphoblastic leukemia.

Authors:  Sandrine Poglio; Daniel Lewandowski; Julien Calvo; Aurélie Caye; Audrey Gros; Elodie Laharanne; Thierry Leblanc; Judith Landman-Parker; André Baruchel; Jean Soulier; Paola Ballerini; Emmanuelle Clappier; Françoise Pflumio
Journal:  Oncotarget       Date:  2016-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.